The efficacy and safety of lenvatinib in patients who did not meet the inclusion criteria of the phase III trial (REFLECT trial) and those with BCLC Stage B hepatocellular carcinoma: A nationwide multicenter study in Japan

被引：0

作者：

Sakamoto, A. ^{[1
]}

Kurosaki, M. ^{[2
]}

Tsuchiya, K. ^{[2
]}

Abe, T. ^{[3
]}

Ogawa, C. ^{[4
]}

Soda, T. ^{[5
]}

Kimura, H. ^{[6
]}

Kondo, M. ^{[7
]}

Tsuji, K. ^{[8
,9
]}

Koichiro, F. ^{[10
]}

Shigeno, M. ^{[11
]}

Jyoko, K. ^{[12
]}

Narita, R. ^{[13
]}

Uchida, Y. ^{[14
]}

Yoshida, H. ^{[15
]}

Akahane, T. ^{[16
]}

Kobashi, H. ^{[17
]}

Mitsuda, A. ^{[18
]}

Marusawa, H. ^{[1
]}

Izumi, N. ^{[2
]}

机构：

[1] Osaka Red Cross Hosp, Gastroenterol, Osaka, Japan

[2] Musashino Res Cross Hosp, Gastroenterol, Tokyo, Japan

[3] Maehashi Red Cross Hosp, Gastroenterol, Maehashi, Japan

[4] Takamatsu Red Cross Hosp, Gastroenterol, Takamatsu, Kagawa, Japan

[5] Fukuoka Red Cross Hosp, Hepatol, Fukuoka, Fukuoka, Japan

[6] Kyoto Daiichi Red Cross Hosp, Gastroenterol, Kyoto, Japan

[7] Otsu Res Cross Hosp, Gastroenterol, Otsu, Shiga, Japan

[8] Hiroshima Res Cross Hosp, Gastroenterol, Hiroshima, Japan

[9] Atom Bomb Survivors, Hiroshima, Japan

[10] Masuda Red Cross Hosp, Gastroenterol, Masuda, Japan

[11] Nagasaki Genbaku Res Cross Hosp, Gastroenterol, Nagasaki, Japan

[12] Matsuyama Res Cross Hosp, Hepatobiliary & Pancreat Dis, Matsuyama, Ehime, Japan

[13] Oita Red Cross Hosp, Hepatol, Oita, Japan

[14] Matsue Red Cross Hosp, Gastroenterol, Matsue, Shimane, Japan

[15] Japanese Red Cross Med Ctr, Gastroenterol, Tokyo, Japan

[16] Ishinomaki Red Cross Hosp, Gastroenterol, Ishinomaki, Miyagi, Japan

[17] Okayama Red Cross Hosp, Gastroenterol, Okayama, Japan

[18] Tottori Red Cross Hosp, Gastroenterol, Tottori, Japan

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

752P

引用

页码：289 / 289

页数：1

共 50 条

[1] The efficacy and safety of lenvatinib in patients who did not meet the inclusion criteria of the phase 3 trial (REFLECT trial) in real-world practice in Japan: A nationwide multicenter study in Japan.
Tsuchiya, Kaoru
Kurosaki, Masayuki
Marusawa, Hiroyuki
Abe, Takehiko
Ogawa, Chikara
Sohda, Tetsuro
Kimura, Hiroyuki
Kondo, Masahiko
Tsuji, Keiji
Furuta, Koichiro
Shigeno, Masaya
Joko, Kouji
Narita, Ryoichi
Uchida, Yasushi
Yoshida, Hideo
Akahane, Takehiro
Kobashi, Haruhiko
Mitsuda, Akeri
Kojima, Yuji
Izumi, Namiki
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[2] Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet REFLECT trial inclusion criteria
Sho, T.
Suda, G.
Ogawa, K.
Kitagataya, T.
Yamada, R.
Shigesawa, T.
Suzuki, K.
Nakamura, A.
Nakai, M.
Natsuizaka, M.
Morikawa, K.
Sakamoto, N.
ANNALS OF ONCOLOGY, 2020, 31 : S145 - S146
[3] Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria
Sho, Takuya
Suda, Goki
Ogawa, Koji
Shigesawa, Taku
Suzuki, Kazuharu
Nakamura, Akihisa
Ohara, Masatsugu
Umemura, Machiko
Kawagishi, Naoki
Natsuizaka, Mitsuteru
Nakai, Masato
Morikawa, Kenichi
Furuya, Ken
Baba, Masaru
Ito, Jun
Yamamoto, Yoshiya
Kobayashi, Tomoe
Meguro, Takashi
Saga, Akiyoshi
Miyagishima, Takuto
Terasita, Katsumi
Takagi, Tomofumi
Kamiyama, Toshiya
Taketomi, Akinobu
Sakamoto, Naoya
HEPATOLOGY RESEARCH, 2020, 50 (08) : 966 - 977
[4] The efficacy and safety of lenvatinib in patients with intermediate-stage hepatocellular carcinoma: A nationwide multicenter study in Japan
Tsuchiya, Kaoru
Kurosaki, Masayuki
Sakamoto, Azusa
Marusawa, Hiroyuki
Ogawa, Chikara
Kondo, Masahiko
Joko, Kouji
Tsuji, Keiji
Kimura, Hiroyuki
Wada, Shuichi
Kobashi, Haruhiko
Uchida, Yasushi
Furuta, Koichiro
Akahane, Takehiro
Kusakabe, Atsunori
Yoshida, Hideo
Matsushita, Tomomichi
Abe, Takehiko
Sohda, Tetsuro
Izumi, Namiki
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[5] A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial)
Ichida, Akihiko
Arita, Junichi
Hatano, Etsuro
Eguchi, Susumu
Saiura, Akio
Nagano, Hiroaki
Shindoh, Junichi
Hashimoto, Masaji
Takemura, Nobuyuki
Taura, Kojiro
Sakamoto, Yoshihiro
Takahashi, Yu
Seyama, Yasuji
Sasaki, Yasuharu
Uemura, Kohei
Kokudo, Norihiro
Hasegawa, Kiyoshi
LIVER CANCER, 2024, 13 (03) : 322 - 334
[6] Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan
Nishikawa, Hiroki
Takeda, Haruhiko
Tsuchiya, Kaoru
Joko, Kouji
Ogawa, Chikara
Taniguchi, Hiroyoshi
Orito, Etsuro
Uchida, Yasushi
Osaki, Yukio
Izumi, Namiki
JOURNAL OF CANCER, 2014, 5 (07): : 499 - 509
[7] Efficacy and safety of transarterial chemoembolization in combination with lenvatinib and tislelizumab for patients with unresectable BCLC-B stage hepatocellular carcinoma classified as beyond up to seven criteria: A retrospective study
Chen, Song
Guo, Wenbo
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[8] REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
Tatsuya Yamashita
Masatoshi Kudo
Kenji Ikeda
Namiki Izumi
Ryosuke Tateishi
Masafumi Ikeda
Hiroshi Aikata
Yasunori Kawaguchi
Yoshiyuki Wada
Kazushi Numata
Yoshitaka Inaba
Ryoko Kuromatsu
Masahiro Kobayashi
Takuji Okusaka
Toshiyuki Tamai
Chifumi Kitamura
Kenichi Saito
Katsuya Haruna
Kiwamu Okita
Hiromitsu Kumada
Journal of Gastroenterology, 2020, 55 : 113 - 122
[9] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Bruix, Jordi
Raoul, Jean-Luc
Sherman, Morris
Mazzaferro, Vincenzo
Bolondi, Luigi
Craxi, Antonio
Galle, Peter R.
Santoro, Armando
Beaugrand, Michel
Sangiovanni, Angelo
Porta, Camillo
Gerken, Guido
Marrero, Jorge A.
Nadel, Andrea
Shan, Michael
Moscovici, Marius
Voliotis, Dimitris
Llovet, Josep M.
JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 821 - 829
[10] REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
Yamashita, Tatsuya
Kudo, Masatoshi
Ikeda, Kenji
Izumi, Namiki
Tateishi, Ryosuke
Ikeda, Masafumi
Aikata, Hiroshi
Kawaguchi, Yasunori
Wada, Yoshiyuki
Numata, Kazushi
Inaba, Yoshitaka
Kuromatsu, Ryoko
Kobayashi, Masahiro
Okusaka, Takuji
Tamai, Toshiyuki
Kitamura, Chifumi
Saito, Kenichi
Haruna, Katsuya
Okita, Kiwamu
Kumada, Hiromitsu
JOURNAL OF GASTROENTEROLOGY, 2020, 55 (01) : 113 - 122

← 1 2 3 4 5 →